United States
US 12,702,714 B2
Treatment of immune evasive tumors
US 12,702,714 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: onCour Pharma, Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- onCour Pharma, Inc.
- Inventors
- John PUISIS; Adam ELHOFY; Tushar MURTHY; Michael BOYNE; Joseph PODOJIL
- Publication date
- 2026-08-11
- Filing date
- 2022-01-28
- Document type
- B2 Granted patent
- Also written as
- US 12,702,714 B2 · US12702714 · 12702714
Abstract
The present disclosure provides methods of treating immune evasive cancers using surface functionalized particles alone or in combination with cancer therapeutics.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free